facebook_pixel
Equity Strategy 30 September 2014
BLUE PHOENIX FINANCIALS PREMIUM CONTENT Not a member? Join Now!
Facebook: Add To Long Positions To Profit From Atlas Server & Innovid

Facebook: Add To Long Positions To Profit From Atlas Server & Innovid

* On 19 Sep 2014, we took partial profit of 40.79% on our Facebook long position: http://www.bluephoenixfinancials.com/equity-strategies/facebook-take-partial-profit-40-79/ * We are still holding our Facebook position established at $24 on 12 June 2013: http://www.bluephoenixfinancials.com/equity-strategies/facebook-uptrend-starting-profit-potential-16-70/ * We now advise Investors to add to Facebook long positions Facebook Debuts Atlas Ad Server Tracking Users Across Devices   * Facebook Inc. is […]

FIND OUT MORE

ETF Strategy 26 September 2014
BLUE PHOENIX FINANCIALS PREMIUM CONTENT Not a member? Join Now!
iShares Nasdaq Biotech ETF: Add To Long Positions. Positive Catalysts Abound

iShares Nasdaq Biotech ETF: Add To Long Positions. Positive Catalysts Abound

* As early as 13 May 2014, we advised to Buy the iShares Nasdaq Biotech ETf (IBB). Target: $275: http://www.bluephoenixfinancials.com/etf-strategies/ishares-nasdaq-biotech-etf-buy-2nd-phase-uptrend-starting/ * On 16 May 2014, IBB traded as low as $225.21 * On 25 Sep 2014, IBB traded as high as $280.07, over and above our $275 target price * We now advice Investors to add […]

FIND OUT MORE

Equity Strategy 25 September 2014
BLUE PHOENIX FINANCIALS PREMIUM CONTENT Not a member? Join Now!
Valeant Pharmaceuticals: Buy. Uptrend Has Started

Valeant Pharmaceuticals: Buy. Uptrend Has Started

* Valeant Pharmaceuticals International, Inc. develops, manufactures, and markets pharmaceuticals, over-the-counter (OTC) products, and medical devices in the areas of eye health, dermatology, and neurology therapeutic classes worldwide. Its pharmaceutical products include Solodyn, an oral antibiotic that treats red and pus-filled pimples, as well as Ziana, Acanya, and Atralin; Wellbutrin XL, a formulation used for the […]

FIND OUT MORE

Equity Strategy 25 September 2014
BLUE PHOENIX FINANCIALS PREMIUM CONTENT Not a member? Join Now!
Advanced Info Service: Buy. Profit From New Fixed-Line Broadband

Advanced Info Service: Buy. Profit From New Fixed-Line Broadband

* Advanced Info Service Public Company Limited operates as a mobile telecommunication company in Thailand. The company operates in three segments: Mobile Phone and Call Center Services, Mobile Phone Sales, and Datanet and Broadband Services. The company provides prepaid and postpaid mobile telephone services on 900 MHz and 1800 MHz frequencies based on Global System for […]

FIND OUT MORE

Equity Strategy 24 September 2014
BLUE PHOENIX FINANCIALS PREMIUM CONTENT Not a member? Join Now!
UCB: Buy. Growth Story Remains Intact

UCB: Buy. Growth Story Remains Intact

* UCB S.A., a biopharmaceutical company, discovers and develops therapies primarily for central nervous system (CNS) disorders and immunology diseases worldwide. Its CNS products include Vimpat and Keppra for epilepsy, and Neupro for Parkinson’s disease and restless legs syndrome; Nootropil for regulating cerebral functions; and Metadate CD for attention deficit hyperactivity disorder. The company is developing […]

FIND OUT MORE